Dr Michael Hubank graduated from University of Cambridge with a degree in Natural Sciences and in 1990 gained a PhD in Molecular Endocrinology from University College London (UCL). After postdoctoral positions at the University of Sussex and Yale University, USA, he returned to UCL in 1999, where he established UCL Genomics, a collaborative genomics research facility which he ran for over 16 years, contributing to many publications in fields ranging from cancer to viral metagenomics.
He began his appointments at the Royal Marsden and ICR in 2016, and now leads the Clinical Genomics Translational Research Team, establishing new genomic assays, and developing and applying diagnostic testing for clinical trials and research studies across the cancer field. In his new role with NHS England he will seek to make the most advanced clinical diagnostic methods available to all NHS cancer patients in a cost effective and equitable manner.
He is particularly interested in implementing genomic testing for circulating tumour DNA in clinically relevant settings, especially for diagnosis and prognosis in pediatric solid tumours, an area of cancer in severe need of better treatment options.